18,999 Followers on Owler
AstraZeneca
is an England-based pharmaceutical firm that develops and commercializes prescription medicines to the treatment of a range of diseases such as oncology and renal... Read moreAstraZeneca
is an England-based pharmaceutical firm that develops and commercializes prescription medicines to the treatment of a range of diseases such as oncology and renal... Read more
Annual Revenue
$43.9B
Employees
83,500
Contacts
Schedule a DemoNew
Funding
$100M
Acquisitions
19
Investments
15
News
AI
Sep 28, 2023
Biospectrum Asia
AstraZeneca introduces AI-based lung screening technology in Malaysia
Partnership
Sep 14, 2023
Marketscreener
AstraZeneca Enters Into 15-Year Partnership With Future Biogas On Biomethane Supply in the UK
Acquisition
Jul 31, 2023
astrazeneca.com
AstraZeneca acquired Pfizer’s Early-stage Rare Disease Gene Therapy Portfolio for $1B
New Office
Jul 11, 2023
Boston Real Estate Times
AstraZeneca unveils new offices in Finland with air-purifying green walls to create a well-being-first work environment
Product Launch
Apr 14, 2023
Business Africa Online
AstraZeneca launches Africa Health Innovation Hub to increase access to healthcare
AstraZeneca Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to AstraZeneca?
AstraZeneca Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$43.9B
AstraZeneca's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 40.9B. Over the last four quarters, AstraZeneca's revenue has decreased by 1%. Specifically, in Q2 2022's revenue was $10.8B; in Q3 2022, it was $11B; in Q4 2022, it was $11.3B; in Q1 2023, AstraZeneca's revenue was $10.9B.
AstraZeneca News
AstraZeneca Press Releases
AstraZeneca Videos
AstraZeneca Headquarters
1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge, EnglandCB2 0AA
44-20-3749-5000
Driving Directions »AstraZeneca Summary
ABOUT
Overview
AstraZeneca UK Limited (LON: AZN) develops pharmaceutical solutions for cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. It discovers new medicines that are designed to improve the health and quality of ...CEO
AstraZeneca's CEO, Pascal Soriot, currently has an approval rating of 81%. AstraZeneca's primary competitors are Pfizer, Novartis, GSK and 12 more.Website
astrazeneca.comCompetitors
View 15 AstraZeneca competitors here.Acquisitions
View 19 companies acquired by AstraZeneca here.Investments
View 15 AstraZeneca investments here.Frequently Asked Questions about AstraZeneca
When was AstraZeneca founded?
AstraZeneca was founded in 1999Who is AstraZeneca's CEO?
AstraZeneca's CEO is Pascal SoriotHow much revenue does AstraZeneca generate?
AstraZeneca generates $43.9B in revenueHow much funding does AstraZeneca have?
AstraZeneca has historically raised $100M in fundingWhere is AstraZeneca's headquarters?
AstraZeneca's headquarters is in Cambridge England, GB
How many employees does AstraZeneca have?
AstraZeneca has 83,500 employeesWhat sector does AstraZeneca operate in?
AstraZeneca is in PharmaceuticalsWho are AstraZeneca's competitors?
AstraZeneca's top competitors are Pfizer, Novartis, GSKWho has AstraZeneca invested in?
AstraZeneca's has invested in companies such as AxBio, Silence Therapeutics, Innate Pharma